Absci Corporation (NASDAQ:ABSI) is among the 12 Best Genomics Stocks to Invest In. Absci Corporation (NASDAQ:ABSI) announced on December 4, 2025, that the first healthy volunteers had been dosed in the Phase 1/2a HEADLINE clinical trial investigating ABS-201, an experimental anti-prolactin…
Continue reading...